English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Of 100 bone marrow transplant recipients, 30 (30%) received a CD4(+) lymphocyte-depleted graft (1x10(6) CD8(+) T lymphocytes/kg of body weight). Replication of Epstein-Barr virus (EBV) was observed in 40 patients (40%). The use of a CD4(+) lymphocyte-depleted graft was the only independent risk factor for replication of EBV (relative risk, 11.5; 95% confidence interval, 5.8-22.8; P&lt;.0001). Nevertheless, EBV load in those patients was not higher than in the rest of patients, and the low EBV load prevented the development of lymphoproliferative disease. These results suggest that the presence of CD8(+) T lymphocytes in the bone marrow graft can control EBV load, thereby reducing the risk of developing lymphoproliferative disease.

the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases

Control of Epstein‐Barr Virus Load and Lymphoproliferative Disease by Maintenance of CD8<sup>+</sup>T Lymphocytes in the T Lymphocyte–Depleted Graft after Bone Marrow Transplantation

Control of Epstein‐Barr Virus Load and Lymphoproliferative Disease by Maintenance of CD8+T Lymphocytes in the T Lymphocyte–Depleted Graft after Bone Marrow Transplantation

Control of Epstein‐Barr Virus Load and Lymphoproliferative Disease by Maintenance of CD8⁺T Lymphocytes in the T Lymphocyte–Depleted Graft after Bone Marrow Transplantation